2545 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 51 | next »
Genei
Gene descriptioni x
Protein classi x
Tissue
Cell
Pathology
Subcellular locationi x
Prognostic p-valuei x
RNA cancer categoryi x
RNA tissue categoryi x
AATKApoptosis associated tyrosine kinaseEnzymes
Predicted intracellular proteins
Predicted membrane proteins
MitochondriaMixedTissue enhanced
ABCA8ATP binding cassette subfamily A member 8Predicted membrane proteins
Transporters
Nucleoplasm
Cytosol
MixedMixed
ABCB1ATP binding cassette subfamily B member 1Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Focal adhesion sites
Cytosol
Renal cancer: 2.95e-4
Pancreatic cancer: 3.33e-4
Tissue enhancedTissue enhanced
ABCC3ATP binding cassette subfamily C member 3Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 4.68e-6
Pancreatic cancer: 9.57e-4
MixedMixed
ABCC6ATP binding cassette subfamily C member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 3.82e-4
Tissue enhancedTissue enhanced
ABCC8ATP binding cassette subfamily C member 8Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Nucleoli
Golgi apparatus
Cytosol
Tissue enrichedTissue enhanced
ABCC9ATP binding cassette subfamily C member 9Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Cytosol
Renal cancer: 1.85e-5
MixedMixed
ABCG2ATP binding cassette subfamily G member 2 (Junior blood group)Cancer-related genes
CD markers
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Plasma membrane
MixedTissue enhanced
ABHD1Abhydrolase domain containing 1Predicted membrane proteins
Predicted secreted proteins
MixedTissue enriched
ABI3BPABI family member 3 binding proteinPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 6.14e-4
MixedMixed
ABLIM2Actin binding LIM protein family member 2Predicted intracellular proteins
Nucleoplasm
Mitochondria
MixedTissue enhanced
ABLIM3Actin binding LIM protein family member 3Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cell Junctions
Renal cancer: 1.28e-4
MixedTissue enhanced
ABOABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferasePredicted membrane proteins
MixedTissue enhanced
AC009014.3Predicted membrane proteins
Liver cancer: 1.63e-4
Pancreatic cancer: 6.13e-4
Tissue enhancedTissue enhanced
AC131097.4Predicted intracellular proteins
Tissue enhancedTissue enhanced
ACER2Alkaline ceramidase 2Enzymes
Predicted membrane proteins
Tissue enhancedGroup enriched
ACHEAcetylcholinesterase (Cartwright blood group)Blood group antigen proteins
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Renal cancer: 3.88e-5
Glioma: 7.16e-4
MixedTissue enhanced
ACOX2Acyl-CoA oxidase 2Enzymes
Predicted intracellular proteins
Vesicles
Cytosol
Tissue enhancedTissue enhanced
ACPTAcid phosphatase, testicularDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
MixedTissue enhanced
ACRBPAcrosin binding proteinPredicted secreted proteins
Nucleoplasm
Vesicles
MixedTissue enriched
ACSM3Acyl-CoA synthetase medium-chain family member 3Enzymes
Predicted intracellular proteins
Renal cancer: 9.88e-6
Ovarian cancer: 1.97e-4
MixedTissue enhanced
ACSS3Acyl-CoA synthetase short-chain family member 3Enzymes
Predicted membrane proteins
MitochondriaRenal cancer: 0.00e+0
MixedMixed
ACTL10Actin like 10Predicted secreted proteins
MixedTissue enriched
ACTN2Actinin alpha 2Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Transporters
Tissue enhancedGroup enriched
ACTR3CARP3 actin-related protein 3 homolog CPredicted intracellular proteins
MixedTissue enriched
ACTRT3Actin related protein T3Predicted intracellular proteins
NucleoplasmEndometrial cancer: 4.11e-4
MixedTissue enriched
ACY3Aminoacylase 3Enzymes
Predicted intracellular proteins
Endometrial cancer: 4.80e-4
MixedTissue enhanced
ADAM11ADAM metallopeptidase domain 11Predicted membrane proteins
Transporters
MixedTissue enhanced
ADAM22ADAM metallopeptidase domain 22Predicted membrane proteins
Predicted secreted proteins
Cell JunctionsMixedTissue enhanced
ADAM28ADAM metallopeptidase domain 28Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membrane
Mitochondria
Endometrial cancer: 3.17e-4
MixedTissue enhanced
ADAM33ADAM metallopeptidase domain 33Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Nuclear speckles
Plasma membrane
MixedMixed
ADAMTS13ADAM metallopeptidase with thrombospondin type 1 motif 13Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
MixedMixed
ADAMTS3ADAM metallopeptidase with thrombospondin type 1 motif 3Cancer-related genes
Predicted secreted proteins
Intermediate filamentsMixedTissue enhanced
ADAMTS5ADAM metallopeptidase with thrombospondin type 1 motif 5Cancer-related genes
Predicted secreted proteins
NucleoplasmRenal cancer: 2.46e-4
Thyroid cancer: 8.54e-4
MixedTissue enhanced
ADAMTS8ADAM metallopeptidase with thrombospondin type 1 motif 8Cancer-related genes
Plasma proteins
Predicted secreted proteins
Endometrial cancer: 1.38e-4
Tissue enhancedTissue enhanced
ADAMTSL1ADAMTS like 1Predicted intracellular proteins
Predicted secreted proteins
MixedTissue enhanced
ADAMTSL3ADAMTS like 3Predicted secreted proteins
VesiclesMixedMixed
ADAMTSL5ADAMTS like 5Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatusMixedTissue enhanced
ADARB2Adenosine deaminase, RNA specific B2 (inactive)Predicted intracellular proteins
MixedTissue enriched
ADCY1Adenylate cyclase 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
MitochondriaMixedTissue enhanced
ADCY2Adenylate cyclase 2Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhancedTissue enhanced
ADCY5Adenylate cyclase 5Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Intermediate filamentsRenal cancer: 7.46e-6
MixedTissue enhanced
ADGRB2Adhesion G protein-coupled receptor B2G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
CentrosomeLung cancer: 4.02e-5
Breast cancer: 6.46e-4
Tissue enhancedTissue enriched
ADGRF1Adhesion G protein-coupled receptor F1G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 1.35e-5
MixedTissue enhanced
ADGRG2Adhesion G protein-coupled receptor G2Disease related genes
G-protein coupled receptors
Plasma proteins
Potential drug targets
Predicted membrane proteins
Plasma membrane
Cytosol
Tissue enhancedTissue enriched
ADGRG6Adhesion G protein-coupled receptor G6Disease related genes
G-protein coupled receptors
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Pancreatic cancer: 2.78e-5
Lung cancer: 8.78e-4
MixedTissue enhanced
ADGRV1Adhesion G protein-coupled receptor V1Disease related genes
G-protein coupled receptors
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Lipid dropletsMixedTissue enriched
ADH1BAlcohol dehydrogenase 1B (class I), beta polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Renal cancer: 7.87e-4
Tissue enrichedGroup enriched
ADH1CAlcohol dehydrogenase 1C (class I), gamma polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Lung cancer: 2.99e-4
Liver cancer: 4.55e-4
Tissue enrichedTissue enhanced
ADHFE1Alcohol dehydrogenase, iron containing 1Enzymes
Predicted intracellular proteins
VesiclesRenal cancer: 4.55e-5
Breast cancer: 5.76e-5
Liver cancer: 9.90e-5
MixedMixed
Page of 51 | next »